Form 4: Phio Pharmaceuticals CFO Reports Stock Transaction
Insider Transaction (Form 4)
Lisa Cabott Carson, Chief Financial Officer of Phio Pharmaceuticals Corp., reported a transaction in 12,888 shares of common stock on September 11, 2026.
Summary
- Tax/exercise-price withholding: disposed of 12,888 Common Stock, $.0001 par value at $1.03 ($13,275) on September 11, 2026; holds 81,112 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Lisa Cabott Carson — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-11 | Tax/exercise-price withholding | Common Stock, $.0001 par value | 12,888 | $1 | $13.3K | 81,112 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-11 | Tax/exercise-price withholding (12,888 shares) |
Keywords
insider transaction, Form 4, PHIO, Phio Pharmaceuticals Corp., neutral, Lisa Cabott Carson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.